The MobiliseMe study: A randomised controlled efficacy trial of a cognitive behavioural therapy smartphone application (ClearlyMe®) for reducing depressive symptoms in adolescents.

Bridianne O'Dea,Sophie H Li,Mirjana Subotic-Kerry,Melinda R Achilles,Andrew J Mackinnon,Philip J Batterham,Helen Christensen,Anna Roberts,Komal Nagendraprasad,Zoe Dudley,Benjamin Gillham,Aliza Werner-Seidler
DOI: https://doi.org/10.1101/2024.11.17.24317363
2024-11-22
Abstract:Aim: This trial evaluated the efficacy of a CBT smartphone application (ClearlyMe®) for reducing depressive symptoms in adolescents when delivered with and without guidance and when compared to an active control. Design: An online three-arm, parallel-group randomised controlled trial. Ethical approval was provided by the University of New South Wales Human Research Ethics Committee. Methods: Adolescents in Australia aged 12 to 17 years with mild to moderate depressive symptoms as measured by the Patient Health Questionnaire-9 Adolescent version (PHQ-A) who were not receiving treatment or experiencing recent or severe suicidality, had access to a smartphone, and parental consent were randomly allocated to receive (i) self-directed use of ClearlyMe®, (ii) ClearlyMe® with SMS-guided support, or the active control (SMS-delivered psychoeducation content) for six weeks. Participants were not directly informed of their allocation and the statistician was blinded for analysis. Outcomes were assessed at baseline, post intervention (primary endpoint: 6-weeks post baseline) and follow-up (secondary endpoint: 4-months post baseline). Primary outcome was change in depressive symptoms from baseline to post intervention as measured by the PHQ-A. Intention-to-treat analyses used multilevel linear modelling. Results: 569 adolescents (Mean age: 15.89, SD: 1.26, 74.2% female) were included in the analyses. The declines in depressive symptoms post intervention in the self-directed (d=0.35, 95%CI:-0.57 — -0.12) and guided conditions (d=0.33, 95%CI: -.0.55 — -0.10) were significantly greater than the control. The effects of self-directed and guided were comparable. There were no differences between the conditions at follow-up for any outcomes. Secondary outcomes followed a similar pattern of change at both endpoints, although there were no differential effects for anxiety symptoms. The risk of adverse events was almost double in the control when compared to the self-directed (IRR: 1.73, 95%CI: 1.15 — 2.62, P=.009) and guided conditions (IRR: 1.98 (95%CI: 1.27 — 3.08, P=.002). Conclusions: ClearlyMe®, when delivered with or without SMS-guided support, was efficacious for short term reductions in depressive symptoms in adolescents when compared to SMS-delivered psychoeducation. Trial registration: Australian New Zealand Clinical Trials Registry (ACTRN12622000131752). Universal Trial Number: U1111-1271-8519.
What problem does this paper attempt to address?
The key problem that this paper attempts to solve is to evaluate the effectiveness of a smartphone application (ClearlyMe®) based on cognitive - behavioral therapy (CBT) in reducing depressive symptoms among adolescents. Specifically, the study aims to compare the effects of the following three conditions: 1. **Self - directed use of ClearlyMe®**: Participants are self - managed only through the application without additional support. 2. **ClearlyMe® with SMS - guided support**: In addition to using the application, participants will receive SMS - guided support once a week to help them use the application better. 3. **Active control group**: Participants receive psycho - educational content via SMS every week instead of using the ClearlyMe® application. ### Main hypotheses of the study: - Compared with the control group, participants using ClearlyMe® (either self - directed or with guided support) will have a more significant reduction in depressive symptoms after 6 weeks. - Whether the effect of ClearlyMe® can be sustained during the 4 - month follow - up. - The impact of ClearlyMe® on secondary outcome measures such as anxiety symptoms, psychological distress, emotional well - being, quality of life, rumination, emotion regulation, and CBT skill acquisition. - Whether participants who receive guided support will show higher app - use engagement compared with those who are only self - directed. - Whether the effect of ClearlyMe® will be moderated by baseline depressive state, gender, and openness to smartphone - based treatment. ### Research background: Adolescent depression is a global health problem, affecting approximately one - third of adolescents and is associated with adverse consequences in multiple areas. Although the Internet provides convenient means of psychological intervention, most existing digital CBT interventions mainly rely on computer devices, and the effectiveness and long - term effects of smartphone applications in this area have not been fully verified. In addition, the role of guided support in increasing application usage and treatment effectiveness is also unclear. Through this randomized controlled trial, researchers hope to determine the short - and long - term effects of the ClearlyMe® application in reducing depressive symptoms among adolescents, as well as the role of guided support therein, thereby providing a scientific basis for future mental health interventions.